Nordic Nanovector
Committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.
Launch date
Employees
Market cap
$35.4m
Enterprise valuation
$26m (Public information from Jun 2023)
Share price
NOK1.018 NANOV.F
Oslo Norway (HQ)
Authorizing premium user...